| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dc25e74fae6933ba4b4330213949278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5b79c784cfcb795c92d42d4fa76f612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7455b32a77e26bea557102bc5952ce94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_599f2f570b3a989fa9076f8465318ddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6db0ecca81d3af0838a9b81f23672399
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26c475bcbe0c24b485b6f37c45cd921f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-6677
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L79-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-0233 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G73-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-35 |
| filingDate |
2010-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219cb8b5848dbab36c1be2a445c96941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_902ad83fe431a496ba3d43f0696ee71e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db7c592f9c239d3ea45dd95a93f4c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96682964537b4630665461716a4ad89a |
| publicationDate |
2014-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8759443-B2 |
| titleOfInvention |
Curable benzoxazine-based compositions, their preparation and cured products thereof |
| abstract |
The invention relates to a curable composition comprising: at least one benzoxazine and at least one toughening additive which can be bound to the at least one benzoxazine in the curing process, characterized in that the toughening additive is distributed in the cured composition in form of discrete domains, and that at least 50% of the discrete domains related to the total amount of discrete domains have a maximum length in any direction of space in the range of 10 nm to 500 nm as determined by transmission electron microscopy (TEM). |
| priorityDate |
2007-12-06^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |